Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05188170
What this trial is testing

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Stanford University 16
Large-scale testing (Phase 3)Study completedNCT04974073
What this trial is testing

Development of PHY606 as Adjunct Therapy for Anemia Patients

Who this might be right for
AnemiaHerbal Interaction
Sheng-Teng Huang 39
Not applicableWithdrawnNCT02127905
What this trial is testing

Unrelated HSCT in Patients With Fanconi Anemia

Who this might be right for
Fanconi Anemia
Neena Kapoor, M.D.
Testing effectiveness (Phase 2)UnknownNCT04913922
What this trial is testing

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT01628029
What this trial is testing

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSleep Disorder
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Testing effectiveness (Phase 2)Study completedNCT03091751
What this trial is testing

Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B

Who this might be right for
Hemophilia B
Grifols Biologicals, LLC 13
Large-scale testing (Phase 3)Study completedNCT04394351
What this trial is testing

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

Who this might be right for
Eosinophilic Esophagitis (EoE)
Regeneron Pharmaceuticals 102
Not applicableEnded earlyNCT01169753
What this trial is testing

Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT04478539
What this trial is testing

Extracorporeal Blood Purification as a Treatment Modality for COVID-19

Who this might be right for
Covid19
Zan Mitrev Clinic 35
Not applicableUnknownNCT03352986
What this trial is testing

Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE

Who this might be right for
Sickle Cell Disease
Cardiologie et Développement 300
Not applicableUnknownNCT05548686
What this trial is testing

Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaAdapted Physical ActivityChronic Pain
University Hospital, Caen 15
Large-scale testing (Phase 3)Study completedNCT02205541
What this trial is testing

Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU

Who this might be right for
Hemolytic Uremic Syndrome of Childhood
University Hospital, Toulouse 100
Large-scale testing (Phase 3)Study completedNCT00207805
What this trial is testing

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre National de Greffe de Moelle Osseuse 202
Testing effectiveness (Phase 2)Active Not RecruitingNCT01589302
What this trial is testing

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

Who this might be right for
Prolymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory/Relapsed Chronic Lymphocytic Leukemia
Kami Maddocks, MD 154
Not applicableLooking for participantsNCT07214753
What this trial is testing

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

Who this might be right for
Severe Eosinophilic Asthma
AstraZeneca 335
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Not applicableStudy completedNCT07532772
What this trial is testing

Transfusion Practices in Intensive Care Units: a Hungarian Nationwide Survey

Who this might be right for
Central Venous Oxygen SaturationAnaemiaLactate+2 more
Pest County Flór Ferenc Hospital 97
Large-scale testing (Phase 3)Looking for participantsNCT06943872
What this trial is testing

Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines 630
Testing effectiveness (Phase 2)Looking for participantsNCT06644183
What this trial is testing

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
LeukemiaRelapsed LeukemiaChronic Lymphocytic Leukemia+2 more
Jennifer R. Brown, MD, PhD 64
Next Page